Transcriptomics

Dataset Information

0

Degradation of AGO2 by TRIM25 drives cancer progression and chemotherapy resistance


ABSTRACT: AGO2, as a key member of the RISC complex, is underexpressed in a variety of tumor cells. It is shown that the E3 ligase TRIM25 is highly expressed in a variety of tumor cells and mediates the degradation of the ubiquitin-proteasome pathway of AGO2. This effect of TRIM25 on AGO2 promotes tumor progression and resistance of tumor cells to chemotherapeutic agents. The specific mechanism is that TRIM25 regulates the level of miR-148b-5p in cells through AGO2, and then regulates the downstream ABCC1. Based on the above results, targeting miR-148b-5p provides a new strategy for the treatment of tumors.

ORGANISM(S): Homo sapiens

PROVIDER: GSE290308 | GEO | 2026/04/25

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

| PRJNA316328 | ENA
2025-09-15 | GSE281314 | GEO
2018-04-25 | GSE73346 | GEO
2025-05-07 | PXD054558 | Pride
2013-02-26 | E-GEOD-36121 | biostudies-arrayexpress
2025-04-04 | GSE264535 | GEO
| PRJNA1227454 | ENA
2018-07-27 | GSE104949 | GEO
2013-02-26 | GSE36121 | GEO
2024-09-20 | GSE276465 | GEO